Shayan Mirshafiee

Dr. Shayan Mirshafiee

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2024 in Journal of International Medical Research
Verified
Journal Article
Open access
SHShokoufeh Hajsadeghi
Shokoufeh Hajsadeghi
ASAli Shamsedini
Ali Shamsedini
PBPooriya Bahadoran
Pooriya Bahadoran
EAErfan Amouei
Erfan Amouei
SMShayan Mirshafiee
Shayan Mirshafiee
Objective: The management and risk stratification of non-massive pulmonary embolism (PE) remain unclear. However, early assessment of PE severity can aid physicians in establishing better treatment milestones. There has been no direct comparison of mortality rates in patients with non-massive PE, and existing data are sometimes contradictory. Therefore, we examined the relationship between the Qanadli index and conventional risk stratifiers in PE. Methods: We retrospectively analyzed 200 consecutively selected patients diagnosed with PE. The assessment included computed tomography pulmonary angiography, electrocardiography, echocardiography findings, outcomes, and a comparison with the Simplified Pulmonary Embolism Severity Index (SPESI) score. Descriptive, regression, and receiver operating characteristic analyses were performed. Results: The mean Qanadli score was 13.5 ± 1.15. Pearson correlation analysis revealed significant associations between the total Qanadli score and several variables: right ventricular enlargement, follow-up ejection fraction, and SPESI score. Although the Qanadli score did not significantly predict mortality, the risk of death increased by 58.8% for each 1-unit increase in the SPESI score. Conclusions: Although the Qanadli index is valuable in assessing PE and guiding treatment strategies, its standalone predictive value for mortality may be insufficient. Therefore, incorporating scoring systems such as the SPESI and echocardiographic findings is recommended for more accurate mortality prediction.

16 May 2024 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
SHShokoufeh Hajsadeghi
Shokoufeh Hajsadeghi
SMShayan Mirshafiee
Shayan Mirshafiee
A healthy 28-year-old woman, presenting with a chronic cough for approximately 6 months, was referred for echocardiography. The images revealed the presence of two masses in each atrium without an inter-atrial septal defect. No additional abnormalities were detected during the clinical examinations. Subsequently, the patient underwent a successful surgical procedure for the removal of the cardiac masses.

5 November 2025 in Journal of International Medical Research
Verified
Journal Article
Open access
SHShokoufeh Hajsadeghi
Shokoufeh Hajsadeghi
EPElham Piryaie
Elham Piryaie
SMShayan Mirshafiee
Shayan Mirshafiee
Background: Isolated cardiac sarcoidosis is a distinct entity of sarcoidosis characterized by disease confined exclusively to the heart, without involvement of other organs. While cardiac sarcoidosis can lead to severe complications such as arrhythmias and heart failure, isolated cardiac sarcoidosis remains understudied, and no systematic review has previously addressed this condition. Key findings: A systematic review of the literature from 1978 to 2025 identified 14 relevant studies, primarily case series. Isolated cardiac sarcoidosis affects both sexes equally, with most patients aged 55–65 years. Compared with multi-organ cardiac sarcoidosis, isolated cardiac sarcoidosis is associated with lower left ventricular ejection fraction and poorer survival. Variability in diagnostic criteria and potential selection bias were key limitations. Conclusion: Isolated cardiac sarcoidosis is a distinct and severe clinical entity with limited available data. Its poorer prognosis underscores the need for specific diagnostic and management guidelines. Future multicenter studies are essential to improve understanding and care for patients with this condition.

1 January 2024 in International Journal of Vascular Medicine
Verified
Journal Article
Open access
SMShayan Mirshafiee
Shayan Mirshafiee
PMPejman Mansouri
Pejman Mansouri
MEMohammadreza Eftekhari
Mohammadreza Eftekhari
MVMohammad Vahidi
Mohammad Vahidi
FBFateme Baharvand
Fateme Baharvand
HVHamed Vahidi
Hamed Vahidi
Objectives: This study is aimed at comparing the effectiveness of ulnar compression and brachial compression in inducing radial artery dilatation.Methods: This randomized crossover study included 30 patients undergoing elective diagnostic transradial coronary angiography. Ulnar compression and brachial compression maneuvers were performed in two groups. Radial artery diameter and cross‐sectional area were measured at baseline and remeasured every 30 s (up to 2 min) after the interventions.Results: Both ulnar compression and brachial compression maneuvers successfully increased radial artery diameter for up to 60 s following the interventions. There were no statistically significant differences between the two groups after adjusting for baseline measurements. However, each treatment group showed a significant increase in indicators up to 60 s, followed by a subsequent decrease. The maximum radial artery diameter occurred at 60 s after the removal of compression in both groups.Conclusion: Ulnar compression and brachial compression maneuvers demonstrated effectiveness in inducing radial artery dilation for a limited duration. These maneuvers may reduce the occurrence of access failure during radial artery cannulation. No significant differences were observed between the two maneuvers, indicating that they can be used interchangeably based on clinician preference. So, because the ulnar compression is simpler and more feasible for the patients, it can be considered instead of brachial compression.Trial Registration:IRCT20230209057372N1.

30 August 2025 in Echocardiography
Verified
Journal Article
Closed access
GEGisou Erabi
Gisou Erabi
SKSarmad Karimi
Sarmad Karimi
ABAssal Behkar
Assal Behkar
DADiba Allafi
Diba Allafi
RSReyhaneh Shahveghar
Reyhaneh Shahveghar
MBMohaddeseh Behjati
Mohaddeseh Behjati

24 August 2024 in The Journal of Vascular Access
Verified
Journal Article
Closed access
MMMohammad Hadi Mansouri
Mohammad Hadi Mansouri
PMPejman Mansouri
Pejman Mansouri
MHMohammad Hashemi
Mohammad Hashemi
SHSeyedeh Melika Hashemi
Seyedeh Melika Hashemi
SMShayan Mirshafiee
Shayan Mirshafiee
AAAfshin Amirpour
Afshin Amirpour
Introduction: Iatrogenic femoral artery pseudoaneurysm (FAP) is a complication following femoral artery puncture, with an incidence rate of 0.2%–5.5% post-cardiac catheterization procedures. Management typically involves observation or interventional treatments such as ultrasound-guided compression (UGC) or ultrasound-guided thrombin injections. This study compares the efficacy and safety of ultrasound-guided autologous blood clot injection (UGCI) with C-clamp vascular closure device-assisted UGC in treating FAP. Materials and methods: Conducted at a high-volume training and research center, this prospective study enrolled patients with iatrogenic FAP post-femoral artery puncture. Patients were randomized into two treatments: UGC with a C-clamp device or UGCI. Primary endpoints were thrombosis induction within 24 h, average procedure time, and length of hospital stay (LOS). Results: The study included 105 patients with 51 undergoing UGCI and 54 undergoing UGC. UGCI achieved a primary success rate of 96% versus 63% for UGC. The mean procedure duration for UGCI was significantly shorter (22 min) compared with UGC (49 min, p ⩽ 0.0001). LOS was also reduced in the UGCI group (1.5 days) compared to the UGC group (4.5 days). Complication rates were low for both procedures, with one deep vein thrombosis and one infection observed in the UGC group. Conclusion: UGCI demonstrated to be a safe, efficient, and faster alternative for treating iatrogenic FAPs with a higher success rate, reduced LOS, and similar low complication rates compared to UGC. This study suggests that UGCI could be considered a preferred method for the management of FAP post-femoral artery catheterization.